These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11427409)

  • 21. To kill or be killed: how HIV exhausts the immune system.
    Gougeon ML
    Cell Death Differ; 2005 Aug; 12 Suppl 1():845-54. PubMed ID: 15832178
    [No Abstract]   [Full Text] [Related]  

  • 22. Expression of the Fas antigen in patients infected with human immunodeficiency virus.
    McCloskey TW; Oyaizu N; Kaplan M; Pahwa S
    Cytometry; 1995 Jun; 22(2):111-4. PubMed ID: 7587741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiretroviral therapy-induced dominant interleukin-2 HIV-1 Gag CD4+ T cell response: evidence of functional recovery of HIV-1-specific CD4+ T cells.
    Tsalimalma K; Kordossis T; Choremi-Papadopoulou E
    Scand J Immunol; 2011 Mar; 73(3):256-65. PubMed ID: 21204901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mathematical model and CD4+ lymphocyte dynamics in HIV infection.
    Hraba T; Dolezal J
    Emerg Infect Dis; 1996; 2(4):299-305. PubMed ID: 8969246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
    Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
    J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens.
    Rinaldo CR; Liebmann JM; Huang XL; Fan Z; Al-Shboul Q; McMahon DK; Day RD; Riddler SA; Mellors JW
    J Infect Dis; 1999 Feb; 179(2):329-36. PubMed ID: 9878015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological and virological failure after antiretroviral therapy is associated with enhanced peripheral and thymic pathogenicity.
    Solomon A; Cameron PU; Bailey M; Dunne AL; Crowe SM; Hoy JF; Lewin SR
    J Infect Dis; 2003 Jun; 187(12):1915-23. PubMed ID: 12792868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads.
    Benveniste O; Flahault A; Rollot F; Elbim C; Estaquier J; Pédron B; Duval X; Dereuddre-Bosquet N; Clayette P; Sterkers G; Simon A; Ameisen JC; Leport C
    J Infect Dis; 2005 May; 191(10):1670-9. PubMed ID: 15838794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal analysis of lymphocyte ratios and HIV-1 intracellular DNA levels in children.
    Saitoh A; Powell CA; Fenton T; Douglas SD; Starr SE; Fletcher CV; Spector SA
    J Infect Dis; 2004 Apr; 189(7):1216-20. PubMed ID: 15031790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Report: immune restoration think tank.
    Lein B
    PI Perspect; 1995 May; (no 16):5-7. PubMed ID: 11362427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The immunopathogenesis of human immunodeficiency virus infection.
    Pantaleo G; Graziosi C; Fauci AS
    N Engl J Med; 1993 Feb; 328(5):327-35. PubMed ID: 8093551
    [No Abstract]   [Full Text] [Related]  

  • 32. CD4 T cell survival after intermittent interleukin-2 therapy is predictive of an increase in the CD4 T cell count of HIV-infected patients.
    Read SW; Lempicki RA; Di Mascio M; Srinivasula S; Burke R; Sachau W; Bosche M; Adelsberger JW; Sereti I; Davey RT; Tavel JA; Huang CY; Issaq HJ; Fox SD; Lane H; Kovacs JA
    J Infect Dis; 2008 Sep; 198(6):843-50. PubMed ID: 18684102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of interleukin-2 in managing infection with the human immunodeficiency virus.
    Piscitelli SC; Minor JR
    Am J Health Syst Pharm; 1995 Mar; 52(5):541-2. PubMed ID: 7606563
    [No Abstract]   [Full Text] [Related]  

  • 34. T cell apoptosis in human immunodeficiency virus type 1 infection: is there a relationship between CD95 sensitivity and thymic regeneration of CD4+ T cells?
    Böhler T
    J Infect Dis; 2001 Nov; 184(9):1225-7. PubMed ID: 11598851
    [No Abstract]   [Full Text] [Related]  

  • 35. Thymic involution and HIV progression.
    Beltz L
    Immunol Today; 1999 Sep; 20(9):429. PubMed ID: 10462744
    [No Abstract]   [Full Text] [Related]  

  • 36. HAART and host: balancing the response to HIV-1. Highly active antiretroviral therapy.
    Morris K
    Lancet; 1998 Nov; 352(9141):1686. PubMed ID: 9853453
    [No Abstract]   [Full Text] [Related]  

  • 37. Further clues emerge for strategies to attack HIV.
    McCarthy M
    Lancet; 1999 Jan; 353(9147):125. PubMed ID: 10023909
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemokines and lymphopoiesis in human thymus.
    Annunziato F; Romagnani P; Cosmi L; Lazzeri E; Romagnani S
    Trends Immunol; 2001 May; 22(5):277-81. PubMed ID: 11323287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on immune-based therapies.
    PI Perspect; 1996 Nov; (No 20):10-4. PubMed ID: 11363965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term effects of interleukin-2 on CD4 cell counts in human immunodeficiency virus-infected patients.
    Ramachandran RV; Katzenstein D; Merigan TC
    J Infect Dis; 1994 Oct; 170(4):1044-6. PubMed ID: 7930706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.